221 related articles for article (PubMed ID: 31336867)
1. A Unique Panel of Patient-Derived Cutaneous Squamous Cell Carcinoma Cell Lines Provides a Preclinical Pathway for Therapeutic Testing.
Hassan S; Purdie KJ; Wang J; Harwood CA; Proby CM; Pourreyron C; Mladkova N; Nagano A; Dhayade S; Athineos D; Caley M; Mannella V; Blyth K; Inman GJ; Leigh IM
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336867
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Mutational and Phenotypic Characterization of New Metastatic Cutaneous Squamous Cell Carcinoma Cell Lines Reveal Novel Drug Susceptibilities.
Perry J; Ashford B; Thind AS; Gauthier ME; Minaei E; Major G; Iyer NG; Gupta R; Clark J; Ranson M
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333825
[TBL] [Abstract][Full Text] [Related]
3. Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.
Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Piipponen M; Kivisaari A; Kallajoki M; Grénman R; Peltonen J; Peltonen S; Quint KD; Bavinck JNB; Kähäri VM
Oncotarget; 2017 Jul; 8(28):45825-45836. PubMed ID: 28526809
[TBL] [Abstract][Full Text] [Related]
4. Eribulin inhibits growth of cutaneous squamous cell carcinoma cell lines and a novel patient-derived xenograft.
Hsu CY; Yanagi T; Maeda T; Nishihara H; Miyamoto K; Kitamura S; Tokuchi K; Ujiie H
Sci Rep; 2023 May; 13(1):8650. PubMed ID: 37244956
[TBL] [Abstract][Full Text] [Related]
5. CircRNA hsa_circ_0070934 functions as a competitive endogenous RNA to regulate HOXB7 expression by sponging miR‑1236‑3p in cutaneous squamous cell carcinoma.
Zhang DW; Wu HY; Zhu CR; Wu DD
Int J Oncol; 2020 Aug; 57(2):478-487. PubMed ID: 32626939
[TBL] [Abstract][Full Text] [Related]
6. Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors.
Yilmaz AS; Ozer HG; Gillespie JL; Allain DC; Bernhardt MN; Furlan KC; Castro LT; Peters SB; Nagarajan P; Kang SY; Iwenofu OH; Olencki T; Teknos TN; Toland AE
Cancer; 2017 Apr; 123(7):1184-1193. PubMed ID: 27906449
[TBL] [Abstract][Full Text] [Related]
7. microRNA-214 Prevents Traits of Cutaneous Squamous Cell Carcinoma via VEGFA and Bcl-2.
Ma X; Wu D; Zhang X; Shao X; Hu G
Technol Cancer Res Treat; 2020; 19():1533033820980098. PubMed ID: 33280526
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of ARMC8 promotes tumorigenesis through activating Wnt/β-catenin pathway and EMT in cutaneous squamous cell carcinomas.
Li X; Zhang C; Yuan Y; Wang Y; Lu S; Zhou Z; Zhen P; Zhou M
J Dermatol Sci; 2021 Jun; 102(3):184-192. PubMed ID: 34016486
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-664 functions as an oncogene in cutaneous squamous cell carcinomas (cSCC) via suppressing interferon regulatory factor 2.
Li X; Zhou C; Zhang C; Xie X; Zhou Z; Zhou M; Chen L; Ding Z
J Dermatol Sci; 2019 Jun; 94(3):330-338. PubMed ID: 31138473
[TBL] [Abstract][Full Text] [Related]
10. lncRNA HCP5 acts as a ceRNA to regulate EZH2 by sponging miR‑138‑5p in cutaneous squamous cell carcinoma.
Zou S; Gao Y; Zhang S
Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195851
[TBL] [Abstract][Full Text] [Related]
11. Tumour-cell-derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma.
Riihilä P; Viiklepp K; Nissinen L; Farshchian M; Kallajoki M; Kivisaari A; Meri S; Peltonen J; Peltonen S; Kähäri VM
Br J Dermatol; 2020 Mar; 182(3):658-670. PubMed ID: 31049937
[TBL] [Abstract][Full Text] [Related]
12. p53-Regulated Long Noncoding RNA PRECSIT Promotes Progression of Cutaneous Squamous Cell Carcinoma via STAT3 Signaling.
Piipponen M; Nissinen L; Riihilä P; Farshchian M; Kallajoki M; Peltonen J; Peltonen S; Kähäri VM
Am J Pathol; 2020 Feb; 190(2):503-517. PubMed ID: 31837949
[TBL] [Abstract][Full Text] [Related]
13. Senescent fibroblast-derived Chemerin promotes squamous cell carcinoma migration.
Farsam V; Basu A; Gatzka M; Treiber N; Schneider LA; Mulaw MA; Lucas T; Kochanek S; Dummer R; Levesque MP; Wlaschek M; Scharffetter-Kochanek K
Oncotarget; 2016 Dec; 7(50):83554-83569. PubMed ID: 27907906
[TBL] [Abstract][Full Text] [Related]
14. Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinoma.
Watt SA; Pourreyron C; Purdie K; Hogan C; Cole CL; Foster N; Pratt N; Bourdon JC; Appleyard V; Murray K; Thompson AM; Mao X; Mein C; Bruckner-Tuderman L; Evans A; McGrath JA; Proby CM; Foerster J; Leigh IM; South AP
Oncogene; 2011 Nov; 30(46):4666-77. PubMed ID: 21602893
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-135b Regulates Leucine Zipper Tumor Suppressor 1 in Cutaneous Squamous Cell Carcinoma.
Olasz EB; Seline LN; Schock AM; Duncan NE; Lopez A; Lazar J; Flister MJ; Lu Y; Liu P; Sokumbi O; Harwood CA; Proby CM; Neuburg M; Lazarova Z
PLoS One; 2015; 10(5):e0125412. PubMed ID: 25938461
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor receptor promotes progression of cutaneous squamous cell carcinoma.
Khandelwal AR; Kent B; Hillary S; Alam MM; Ma X; Gu X; DiGiovanni J; Nathan CO
Mol Carcinog; 2019 Oct; 58(10):1715-1725. PubMed ID: 31254372
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies.
Al-Rohil RN; Tarasen AJ; Carlson JA; Wang K; Johnson A; Yelensky R; Lipson D; Elvin JA; Vergilio JA; Ali SM; Suh J; Miller VA; Stephens PJ; Ganesan P; Janku F; Karp DD; Subbiah V; Mihm MC; Ross JS
Cancer; 2016 Jan; 122(2):249-57. PubMed ID: 26479420
[TBL] [Abstract][Full Text] [Related]
18. Pre-mRNA processing factor 3 enhances the progression of keratinocyte-derived cutaneous squamous cell carcinoma by regulating the JAK2/STAT3 pathway.
Zuo S; Li X; Bao W; Li S
Sci Rep; 2020 Jun; 10(1):8863. PubMed ID: 32483193
[TBL] [Abstract][Full Text] [Related]
19. Long Noncoding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity.
Piipponen M; Nissinen L; Farshchian M; Riihilä P; Kivisaari A; Kallajoki M; Peltonen J; Peltonen S; Kähäri VM
J Invest Dermatol; 2016 Aug; 136(8):1701-1710. PubMed ID: 27049681
[TBL] [Abstract][Full Text] [Related]
20. Review of systemic agents in the treatment of advanced cutaneous squamous cell carcinoma.
Petersen ET; Ahmed SR; Chen L; Silapunt S; Migden MR
Future Oncol; 2019 Sep; 15(27):3171-3184. PubMed ID: 31382778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
